Dopamine D3 Receptor Occupancy in Bipolar Depression

NCT05060549 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding decision

Conditions

Bipolar Depression

Interventions

DRUG: Cariprazine

Sponsor

New York State Psychiatric Institute